Atezolizumab (atezo) and tumour microenvironment in early triple-negative breast cancer (eTNBC): Exploratory biomarker analysis from IMpassion031 Meeting Abstract


Authors: Harbeck, N.; Duan, C.; DuPree, K.; Chang, C. W.; Barrios, C. H.; Zhang, H. A.; Saji, S.; Jung, K. H.; Telli, M. L.; Liste Hermoso, M.; Chui, S.; Dieterich, M.; Mittendorf, E. A.; Molinero, L.
Abstract Title: Atezolizumab (atezo) and tumour microenvironment in early triple-negative breast cancer (eTNBC): Exploratory biomarker analysis from IMpassion031
Meeting Title: ESMO Congress 2023
Journal Title: Annals of Oncology
Volume: 34
Issue: Suppl. 2
Meeting Dates: 2023 Oct 20-24
Meeting Location: Madrid, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2023-10-01
Start Page: S1149
End Page: S1150
Language: English
ACCESSION: WOS:001087480203230
DOI: 10.1016/j.annonc.2023.09.1260
PROVIDER: wos
Notes: Meeting Abstract: 2232O -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Hong Zhang
    54 Zhang